A drug first discovered over 50 years ago and long used as a medicine for coughs and respiratory illnesses appears to show promise in treating a very different kind of sickness: Parkinson's disease.

有一种药50年前被发现，一直用于治疗咳嗽和呼吸道疾病，现在被发现能治疗一种完全不同的疾病：帕金森病。

Ambroxol, an active ingredient in cough mixtures since the 1970s, has been investigated in recent years for its apparent potential to halt the progression of Parkinson's, and already this year, the drug has passed two important milestones that may bring us closer to a much-hoped-for treatment.

20世纪70年代以来氨溴索一直是止咳药的有效成分，近些年调查了它在抑制帕金森病发展中的潜在作用，今年已经通过了两个重要测试阶段，可能使我们朝着期待已久的治疗目标更近了一步。

Last month, a multi-institutional team of researchers led by University College London (UCL) reported the results of a small Phase II clinical trial suggesting that ambroxol was safe and well-tolerated in human patients with Parkinson's disease, while hinting at possible neuroprotective effects that need to be examined further in subsequent trials.

上个月伦敦大学学院带领的多机构研究团队报告了小型Ⅱ期临床试验结果，结果显示对于帕金森患者来说氨溴索很安全，而且耐受性良好。同时报告中暗示了它可能有神经保护作用，还需要在以后的试验中做进一步检验。

【止咳糖浆有望治疗帕金森?】相关文章：

★ 大学生空腹豪饮的趋势令人担忧

★ 你最喜欢自己哪一点?

★ 马斯克的SpaceX测试了最新的飞船火箭

★ 国家远程医疗自闭症注册登记平台今日向社会开放

★ 有哪些老外的美食让中国人恶心?

★ 心理学上，人为何会有色彩偏好

★ 人过50岁会后悔什么？

★ 警务调度员也有脆弱的时候

★ 这十个景点趁早去看看 以后可能就看不到了......

★ 儿子小小的一句话，让我深深感动